Clinical Trial Update: HP Pyruvate MRI in Cancers [Phase 1, Phase 2]

View source ↗

Summary

A clinical study evaluating hyperpolarized pyruvate MRI for cancer imaging, spanning Phase 1 and Phase 2, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Image, Warburg Effect | Phase 1, Phase 2 | Status: RECRUITING